StageGrowth Equity | Alive
CLINITHINK supplies server and cloud-based tools that convert free-form medical text into fully-structured data streams, which can be used by applications and analytical tools that demand structured inputs. Cinithink's Clix software uses natural language processing and proprietary post-processing algorithms to construct fully-coded ICD-9, ICD-10, and SNOMED strings.
Missing: CLINITHINK's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: CLINITHINK's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing CLINITHINK
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CLINITHINK is included in 3 Expert Collections, including Artificial Intelligence.
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.
Latest CLINITHINK News
May 24, 2023
and safety while saving NHS trusts hundreds of thousands of pounds annually Improve patient care and patient safety through reduced ‘episodes of care’ Improve clinician satisfaction and good clinical judgement through more informed patient history AI healthtech projected to save up to 55,000 clinician hours for the participating NHS trust The technology can rapidly process millions of medical records in hours instead of weeks Latest software projected to recoup upwards of 3% of drug costs for the participating NHS trust Health technology AI leader, Clinithink , has signed a five-year contract with software provider The Access Group (Access), which is set to improve patient care, relieve workloads for stretched clinicians and deliver significant savings to NHS trusts. Using the world’s first AI which can understand unstructured medical notes and working with East London NHS Foundation Trust in a pilot phase, the Access Rio Patient Insight software is projected to save upwards of £840,000 of a trust’s operational costs per year. This includes an estimated 1% reduction in admissions, equating on average of £425,000 and an additional £192,000 drug cost savings. It also includes a 25% reduction in follow-up appointments – resulting in shorter waiting times for patients. The new software harnesses Clinithink’s CLiX unlock technology to provide clinicians with a clear timeline summary of relevant patient information, such as medication and risks, on one screen, without needing to read through extensive progress notes, which can run to hundreds of pages. The AI solves this problem by rapidly reading and understanding the rich, narrative content in the entire record, saving valuable time and giving doctors easy access to the information they need. Clinithink’s Clinical Natural Language Processing (CNLP) solution, CLiX ® extracts valuable data from the lengthy, unstructured patient notes. This is often the part of the file that contains the most valuable clinical patient information. The software then turns the data into insights for the doctor to action. It also identifies the most appropriate ‘SNOMED CT’ code – a clinical vocabulary used in electronic health records – saving further time. The technology will lead to better information sharing among clinicians, improved patient safety and more accurate prescribing – reducing the number of ‘care episodes’. It will also free up thousands of hours of clinician time, when rising workloads and staff shortages are placing healthcare professionals under greater pressure. Access, which provides software including electronic patient records for around 60 of the UK’s community mental health trusts, launched the system in April. Clinithink and Access first introduced the AI technology in 2020, as part of a pilot project at one of the UK’s largest mental health providers, East London Foundation Trust (ELFT). As part of its ongoing development, the software is now being trialled at other large mental health providers. Chris Tackaberry, co-founder and CEO at Clinithink said: “This is an exciting partnership, which will deliver significant benefits to patients, clinicians and NHS trusts across the UK at a time when resources are undeniably stretched. By placing the patient at the centre of an integrated service and gaining an up-to-date, single view of an individual’s healthcare, we can start to deliver a truly joined-up health service. Harnessing and understanding unstructured medical data creates enormous opportunities to transform a patient’s care, while also saving clinicians’ valuable time and reducing NHS costs.” Lee Meredith, head of product in health at The Access Group said: “At The Access Group, we are proud to be partnering with Clinithink to bring this ground-breaking AI technology to healthcare providers. The Access Rio EPR platform will be significantly enhanced with the Patient Insight module, powered by Clinithink’s CLiX software, and has the potential to revolutionise the way clinicians access and use patient data, providing them with actionable insights from unstructured medical notes in a fraction of the time it would take to read through them manually. By streamlining this process, clinicians can save valuable time and focus on delivering better patient care, while healthcare providers can benefit from reduced operational costs, improved patient safety, and more accurate prescribing. The Patient Insight module is fully integrated with the Rio EPR solution providing a seamless interface for the user. We are excited to see the positive impact this technology will have on our customers and the wider healthcare industry.” Toby Baldwin, interim chief clinical digital officer at East London NHS Foundation Trust said: “We are pleased to have worked with Clinithink and The Access Group within the pilot phase of this exciting new technology addressing patient data analysis. In the limited time a clinician has to prepare for an appointment, the in-depth analysis of the unstructured notes that this system can achieve simply wouldn’t be possible manually. As a result, this technology has the potential to really improve both patient care and patient safety through safer prescribing, as an example.”
CLINITHINK Frequently Asked Questions (FAQ)
When was CLINITHINK founded?
CLINITHINK was founded in 2009.
Where is CLINITHINK's headquarters?
CLINITHINK's headquarters is located at 41 Corsham Street, London.
What is CLINITHINK's latest funding round?
CLINITHINK's latest funding round is Growth Equity.
Who are the investors of CLINITHINK?
Investors of CLINITHINK include TT Capital Partners, MSD Global Health Innovation Fund, Vanguard Atlantic and Development Bank of Wales.
Who are CLINITHINK's competitors?
Competitors of CLINITHINK include Jvion.
Compare CLINITHINK to Competitors
Prealize uses machine learning to responsibly contain healthcare spending for patients and their health insurers by predicting those who will be high-cost patients in the coming year. Its solutions include RiskInsight for underwriters seeking to find future high-cost claimants at the individual and group level to make more accurate pricing decisions, ConsumerConnect for consumer experience, member experience, and digital strategy leaders seeking to engage more members and improve outcomes, ConsumerConnect High Touch for clinical, health services, care management, and physician leaders seeking to prioritize future high-cost claimants and intervene earlier, and Health Equity for all healthcare leaders seeking to close the equity gap and provide holistic support for members based on predictive, actionable insights. The company was founded in 2015 and is based in San Francisco, California.
Decode Health is a precision medicine analytics company that fuels collaboration within pharmaceutical, diagnostic, and technology companies. The company leverages its platform and expertise in genomics, clinical data, social determinants of health, and other healthcare data sources, to bring actionable insights into focus quickly. It creates data assets, products, and services that improve patient outcomes and reduce costs. Projects include genomic data creation, biomarker discovery, RNA diagnostics, and broader population health analytics. Decode Health was founded in 2019 and is headquartered in Nashville, Tennessee.
Merative is a data, analytics, and technology partner for the health industry, including providers, health plans, employers, life sciences companies, and governments. The company works with clients to drive progress. Merative helps clients orient information and insights around the people they serve to improve decision-making and performance for better health experiences. It was formerly known as the Watson Health business of IBM and rebranded to Merative in June 2022. Merative was founded in 2022 and is based in Ann Arbor, Michigan.
ClosedLoop operates as a healthcare data science platform. It enables providers, payers, and value-based care organizations to make accurate, explainable, and actionable predictions of individual-level health risks, improve outcomes, and reduce costs. The company was founded in 2017 and is based in Austin, Texas.
Arcadia is a population health management technology company that offers various data-related insights solutions. It helps providers and health plans deliver insights to advance care and research, drive strategic growth, and ensure financial success. It caters its services to healthcare enterprises. The company was founded in 2002 and is based in Boston, Massachusetts.
CloudMedx automates healthcare processes and provides a single unified data platform. It offers operations explorer, clinical explorer, financial explorer, chronic conditions explorer, and more. The company was founded in 2015 and is based in Palo Alto, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.